Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
7,041.28
(
0.26%
)
US TECH 100
25,608.00
(
0.44%
)
Dow Jones
48,578.72
(
0.24%
)
Brent Oil
95.01
(
2.54%
)
Bitcoin
75,006.64
(
0.24%
)
News Focus
News Focus
Post# of 517350
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

WilliamMunny

Send PM Follow Ignore
Followers 8
Posts 494
Boards Moderated 0
Alias Born 03/06/2022

WilliamMunny

Re: boi568 post# 485098

Thursday, 03/20/2025 10:25:50 PM

Thursday, March 20, 2025 10:25:50 PM

Post# of 517350
Agree, boi, but I am talking about compliance in the real world. If 3-71 improves cognition to some degree and has fewer side effects, I believe, quite aside from efficacy on PANSS, it could generate better compliance than the BMY (Karuna) drug outside of inpatient populations.
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Detailed Quote
Recent AVXL News
More AVXL News